Seeking Alpha

Forbes' Matthew Herper notes that the CEO of Fougera, which Novartis is buying for $1.525B, is...

Forbes' Matthew Herper notes that the CEO of Fougera, which Novartis is buying for $1.525B, is Brian Markison, who was CEO of King Pharmaceuticals when it was sold to Pfizer for $3.6B in 2010. Herper speculates that Markison won't be short of job offers, especially if there are any other drug firms looking to get bought.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs